Submission of Annual Secretarial Compliance Report for the Financial Year ended 31st March, 2026.
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anuh Pharma Ltd has submitted its Annual Secretarial Compliance Report for the Financial Year ended 31st March 2026, as required under SEBI LODR Regulation 24A. The report was issued by GHV & Co., Practicing Company Secretaries. The auditors found that the company has complied with all SEBI regulations, including LODR, Insider Trading, ICDR, and Takeover regulations, with no violations noted for the review period. The only pending matter relates to a previous year issue where BSE had levied a fine of INR 2,14,760 for a typographical error in the Audit Committee composition filing for Q1 FY25. The company has requested waiver of this fine and the application is pending with BSE.
This is a positive compliance filing showing the company maintained good governance standards during FY 2025-26. All 13 compliance parameters were met with no penalties or regulatory actions during the period. The pending fine waiver application for a prior year administrative error poses minimal risk to shareholders.